Personalis Inc (PSNL)
1.27
+0.06
(+4.96%)
USD |
NASDAQ |
Apr 19, 14:39
Personalis Cash from Financing (TTM): 11.03M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.03M |
September 30, 2023 | 1.726M |
June 30, 2023 | 2.196M |
March 31, 2023 | 0.851M |
December 31, 2022 | 1.366M |
September 30, 2022 | 2.202M |
June 30, 2022 | 0.936M |
March 31, 2022 | 7.366M |
December 31, 2021 | 169.70M |
September 30, 2021 | 169.29M |
June 30, 2021 | 288.48M |
Date | Value |
---|---|
March 31, 2021 | 283.79M |
December 31, 2020 | 121.27M |
September 30, 2020 | 120.80M |
June 30, 2020 | -20.57M |
March 31, 2020 | 120.88M |
December 31, 2019 | 134.95M |
September 30, 2019 | 134.52M |
June 30, 2019 | 156.98M |
March 31, 2019 | 13.98M |
December 31, 2018 | -0.591M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-20.57M
Minimum
Jun 2020
288.48M
Maximum
Jun 2021
89.88M
Average
120.80M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Senseonics Holdings Inc | 20.37M |